Mashup Score:66
JACC: Cardiovascular Imaging# HCM
Mashup Score:24
American Journal of CardiologyImpact of Body Mass Index on Mortality in Hospitalized Patients With Hypertrophic Cardiomyopathy - 1 month
Mashup Score:24
Although obesity is associated with increased phenotypic expression in patients with hypertrophic cardiomyopathy (HC), the effect of body mass index (BMI) on in-hospital mortality...
-
Underweight and morbidly obese patients with #HCM both at increased mortality risk. Slight obesity protective. @jay_sreenivasan @ErinMichos @WestchesterMed @4hcm @LindsayLuvDavis @CSHeartResearch https://t.co/Dy3ucXe5YO - view on twitter
More coverage:
#hcm
Mashup Score:22
NatureSingle-nucleus profiling of human dilated and hypertrophic cardiomyopathy – Nature - 5 days
Mashup Score:22
Heart failure encompasses a heterogeneous set of clinical features that converge on impaired cardiac contractile function1,2 and presents a growing public health concern. Previous...
-
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy | Nature #DCM #HCM https://t.co/JK9uDYgbXS - view on twitter
Mashup Score:21
SpotifyDon’t Miss a Beat: oHCM and Mavacamten - 3 weeks
Mashup Score:21
Listen to this episode from Don’t Miss a Beat on Spotify. A first-in-class allosteric and reversible inhibitor selective for cardiac myosin approved based on...
-
This month on #DontMissABeat, @mvaduganathan & I were honored to discuss #EXPLORER_HCM & #mavacamten w/ guest #HCM expert @tikuowens! ✅trial design &🔑results ✅#RCT endpoint considerations for #HCM ✅magnitude of KCCQ benefit ✅implementation https://t.co/PuT52ErjAq https://t.co/PuT52ErjAq - view on twitter
Mashup Score:19
OUP AcademicAbstractAims. Genetic testing in relatives of hypertrophic cardiomyopathy (HCM) patients leads to early identification of pathogenic DNA variant carriers...
-
Contemporary family screening in #HCM : the role of #whyCMR In this study , subjects with normal ECG/TTE results were reclassified in a low number of cases, justifying screening with #ECG and #TTE in G+ relatives https://t.co/f3wqpiB8LV #EHJCVI @ESC_Journals @GeraldMaurer https://t.co/f3wqpiB8LV - view on twitter
Mashup Score:17
symptomaticohcmprogram.comMedia Hub - 2 weeks
Mashup Score:17
IMPORTANT SAFETY INFORMATION WARNING: RISK OF HEART FAILURE CAMZYOS reduces left ventricular ejection fraction (LVEF) and can cause heart failure due to systolic dysfunction....
-
Please join me at noon tomorrow 6/14 as we kickoff the first of several national talks on prescribing Mavacamten in #HCM. Register at link ⬇️ @bmsnews @AnkurKalraMD @purviparwani @baileyannRN @4hcm @HCMBeat https://t.co/b6uiAwiPvm - view on twitter
More coverage:
#hcm
Mashup Score:14
SpringerLinkBackground Currently, there is no patient-reported outcome (PRO) instrument specifically designed to evaluate hypertrophic cardiomyopathy (HCM). Objective We present the development and psychometric validation...
-
#HCM Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) | Based on EXPLORER/MAVERICK @IacopoOlivotto @bmsnews @mmartinezheart @MasriAhmadMD @CSHeartResearch @AnkurKalraMD @jct_ucb https://t.co/pG2NprK1xx - view on twitter
More coverage:
#hcm
Mashup Score:12
FrontiersObjectives: To identify previously unrecognized genetic variants and clinical variables associated with the ICD-10 (International Classification of Diseases 10)-based diagnosis of hypertrophic cardiomyopathy in...
-
Congratulations to @agyftoMD @wang_libin on their latest publication in @FrontGenetics. This adds to notion of polygenic contributors to sarcomere mutation-negative hypertrophic cardiomyopathy (#HCM). @UMmedschool @UM_Cardiology @ummidtownim @uk_biobank https://t.co/3apwtcGoEd https://t.co/3apwtcGoEd - view on twitter
More coverage:
#hcm
Mashup Score:11
www.radcliffecardiology.comHypertrophic Cardiomyopathy in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies - 2 weeks
Mashup Score:11
In this two-part hypertrophic cardiomyopathy video series, Dr Ahmad Masri discusses important cardiomyopathy data that has been presented at the ESC–HFA annual congress 2022...
-
On @radcliffeCARDIO I discuss #HCM #phenocopies and provide case examples illustrating how to think about HCM. #CardioTwitter https://t.co/gobXokccAB - view on twitter
Hypertrophic cardiomyopathy (HCM) is a common form of inherited cardiomyopathy with a prevalence in the general population reported as 0.2% in different international studies.1...
-
Differences in clinical presentation and patient management could explain the less favorable outcomes of #HCM patients from the Asian center compared to the Eurpean Centers. @VDelgadoGarcia @chinghuisia #AHAJournals https://t.co/JLTQWsZkee - view on twitter
Abstract Background Left ventricular (LV) apical aneurysms in hypertrophic cardiomyopathy (HCM) are a recognized risk marker for adverse cardiovascular events. There is variable practice...
Clinical Characteristics and Prognostic Importance of LV Apical Aneurysms in #HCM 📌Aneurysm size ≥2 cm was associated with a 5-year #SCD rate of 9.7% 📌If Aneurysm size ≥2 cm ; consideration for prophylactic anticoagulant and P’ prevention of #ICDs https://t.co/UfQTR1Yn80 https://t.co/UfQTR1Yn80 - view on twitter